Synthetic Biology

Press Release and Media Advisory

NGOs Denounce Corporate Greenwashing: ‘No to Dubious Biotech-fixes for Climate Change’

Montreal, 16 July 2009. Several groups including Greenpeace, ETC Group and Biofuelwatch are warning that the biotech lobby will mount a major green-washing public relations exercise during the Sixth Annual Conference on Industrial Biotechnology and Bioprocessing that will be held at the Palais de congrès (19-22 July 2009).

During the Conference, the biotech industry will present various untested biotechnology innovations as solutions to climate change. “The biotech industry is seeking massive public and private investment for their untested technologies, whose health and environmental impacts have not been fully examined. Rather than be duped by yet another green mirage, governments should invest in real solutions to climate change and get serious about reducing CO2 emissions and commit to... Read more

Communiqué et avis aux médias

Des ONG dénoncent l’écomarketing des entreprises biotechnologiques « Non aux prétendus remèdes miracles aux changements climatiques »

Montréal, le 16 juillet 2009. Plusieurs organisations environnementales, parmi lesquelles figurent Greenpeace, ETC Group et Biofuelwatch préviennent que le lobby biotechnologique s’apprête à se lancer dans un vaste exercice de relations publiques destiné à faire accepter certaines innovations comme étant des solutions écologiques. La 6e Conférence annuelle sur la biotechnologie industrielle aura lieu au Palais des congrès de Montréal du 19 au 22 juillet prochains.

Pendant la conférence, l’industrie biotechnologie va présenter diverses innovations comme s’il s’agissait de véritables solutions aux... Read more

Who Owns Nature?

In this 100th issue of the ETC Communiqué we update Oligopoly, Inc. – our ongoing series tracking corporate concentration in the life industry. We also analyze the past three decades of agribusiness efforts to monopolize the 24% of living nature that has been commodified, and expose a new strategy to capture the remaining three-quarters that has, until now, remained beyond the market economy.

À qui appartient la nature?

Pouvoir des grandes sociétés et ultime frontière de la marchandisation du vivant

Problèmes, obsessions et occasions : une préface

TIl y a trente ans, l’humanité avait un problème; la science avait une obsession; et l’industrie tenait une occasion. Notre problème était l’injustice. Les rangs des affamés ne cessaient de grossir et les rangs des agriculteurs, de s’affaiblir. De son côté, la science était obsédée par la biotechnologie – la possibilité de modifier génétiquement les cultures et le bétail (et l’être humain) pour les doter de traits qui allaient régler tous nos problèmes. L’industrie agroalimentaire tenait l’occasion de prélever l’énorme valeur ajoutée tout au long de la... Read more

Who Owns Nature?

New report warns of corporate concentration, commodification of nature; highlights global resistance grounded in "Food Sovereignty"

ETC Group today releases a 48-page report, "Who Owns Nature?" on corporate concentration in commercial food, farming, health and the strategic push to commodify the planet's remaining natural resources.

In a world where market research is becoming increasingly proprietary and pricey, ETC Group's report names names, discloses market share and provides top 10 industry rankings up and down the corporate food chain. Not all the corporations identified in ETC Group's new report are household names, but collectively they control a staggering share of the commercial products found on industrial farms, in our refrigerators and medicine cabinets.

An international advocacy... Read more

ETC Group News Release 9 October 2008 www.etcgroup.org

The Last Straw?  As Extreme Genetic Engineers Gather in Hong Kong, Critics Warn of Corporate Grab on Plant Life SynBio 4.0 = SynBio-4-profit

Synthetic biologists, a brave new breed of science entrepreneurs who engineer life-forms from scratch, will hold their largest-ever global gathering in Hong Kong, October 10-12, known as "Synthetic Biology 4.0." Although most people have never heard of synthetic biology, it's moving full speed ahead fueled by giant agribusiness, energy and chemical corporations with little debate about who will control the technology, how it will be regulated (or not) and despite grave concerns surrounding the safety and security risks of designer organisms. Corporate investors/partners include BP, Chevron, Shell, Virgin Fuels, DuPont, Microsoft, Cargill and Archer Daniels Midland.

... Read more

Click on the 'Download PDF' icon above to download ETC Group's 12-page report, Commodifying Nature's Last Straw?  Extreme Genetic Engineering and the Post-Petroleum Sugar Economy. (PDF2 above is a higher resolution file.)

(PDF2 above contains the complete poster)

News Release Coalition Against Biopiracy Wednesday, 21 May 2008 www.captainhookawards.org www.etcgroup.org

Captain Hook Awards for Biopiracy 2008

The Coalition Against Biopiracy* exposes Hooks and celebrates Cogs

Winners announced at the UN’s Biodiversity Convention in Bonn

Today the world learned which corporations, governments, institutions and individuals earned a spot in biopiracy’s hall of shame when the Coalition Against Biopiracy (CAB) announced the winners of the 5th Captain Hook Awards at a lunch-time ceremony during the Ninth Conference of the Parties (COP9) to the Convention on Biological Diversity (CBD) in Bonn, Germany.

“The Maritim Hotel, where the CBD meets this week and next, was the perfect place to... Read more

ETC Group News Release 24 January 2008 www.etcgroup.org

Venter Institute Builds Longest Sequence of Synthetic DNA (that Doesn’t Work)  “It’s not how long – but how wise” cautions ETC Group

ETC Group today renewed its call for a moratorium on the release and commercialization of synthetic organisms, asserting that societal debate on the oversight of synthetic biology is urgently overdue. The renewed call came as J. Craig Venter’s research team announced that it has constructed a bacterial-length synthetic genome in the lab using mail-order synthetic DNA sequences. They’ve named the synthetic genome, Mycoplasma genitalium JCVI-1.0, and it’s similar to its counterpart in nature, a genital bacterium with the smallest known genome of any free living organism. The announcement is not breaking news because the work had been previously reported, but the details were published today in Science.

“Venter is... Read more

ETC Group News Release 17 October 2007 www.etcgroup.org

Syns of Omission: Civil Society Organizations Respond to Report on Synthetic Biology Governance from the J. Craig Venter Institute and Alfred P. Sloan Foundation A report released today on policy options for governance of synthetic biology is a disappointing effort that fails to address wider societal concerns about the rapid deployment of a powerful and controversial new technology. Synthetic biology aims to commercialize new biological parts, devices and living organisms that are constructed from synthetic DNA - including dangerous pathogens. Synthetic biologists are attempting to harness cells as tiny factories for industrial production of chemicals, including pharmaceuticals and fuels. ETC Group describes the synthetic biology approach as "extreme genetic engineering."

The report, authored by scientists and employees from the J.... Read more

ETC Group News Release 28 June 2007 www.etcgroup.org

Synthia’s last hurdle?

Synthia – the “Original Syn” artificial microbe – may have jumped a hurdle that Dolly – the cloned sheep – never could

Synthia, the (theoretical) human-made synthetic microbe – still barely a twinkle in J. Craig Venter’s eye – may be in search of a surrogate micro-mom sometime very soon. According to a research report released today in Science magazine, Synthia (the subject of a patent application discovered by ETC Group a few weeks ago -see “Goodbye Dolly -- Hello Synthia!”) may have overcome her last hurdle. The report, authored by Craig Venter and his colleagues at Synthetic Genomics Inc., claims to have inserted a foreign bacterial genome into the cell of another... Read more

*this publication also available in German. ETC Group News Release 25 June 2007 www.etcgroup.org

The G(e)nomes of Zurich: Civil Society Calls for Urgent Controls on Synthetic Life*

Follow Syn Bio meeting on ETC Group’s blog

Scientists and industrialists in the controversial new field of synthetic biology (building life-forms from scratch) are meeting in Zurich, Switzerland this week amidst claims that the world’s first entirely human-made organism may be only weeks away from creation. Swiss and international civil society groups are calling for swift action to control this technology but the scientists themselves are advancing pre-emptive proposals to evade regulation. As scientists meet in Zurich, the UK’s Royal Society and the Swiss government announce plans to investigate synthetic biology.

Synthetic Biology 3.0... Read more

Patenting Pandora's Bug

Goodbye, Dolly...Hello, Synthia! J. Craig Venter Institute Seeks Monopoly Patents on the World's First-Ever Human-Made Life Form

ETC Group Will Challenge Patents on "Synthia" - Original Syn Organism Created in Laboratory

Ten years after Dolly the cloned sheep made her stunning debut, the J. Craig Venter Institute is applying for a patent on a new biological bombshell - the world's first-ever human-made species. The novel bacterium is made entirely with synthetic DNA in the laboratory.

The Venter Institute - named for its founder and CEO, J. Craig Venter, the scientist who led the private sector race to map the Human Genome - is applying for worldwide patents on what they refer to as "Mycoplasma laboratorium." In the tradition of 'Dolly,' ETC has nicknamed this synthetic organism (or... Read more

News ReleaseETC Group January 16, 2007www.etcgroup.org

Extreme Genetic Engineering: ETC Group Releases Report on Synthetic Biology

Findings to be presented at World Social Forum in Nairobi - 20-25 January

"Genetic engineering is passé," said Pat Mooney, Executive Director of ETC... Read more

Nanotech Rx

Medical applications of Nano-scale technologies: What Impact on Marginalized communities?

Issue: Medical applications of nano-scale technologies have the potential to revolutionize healthcare by delivering powerful tools for diagnosing and treating disease at the molecular level. But the current zeal for nano-enabledmedicines could divert scarce medical R&D funds away from essential health services and direct resources away from non-medical aspects of community health and wellbeing. Although nanomedicine is being touted as a solution to pressing health needs in the global South, it is being driven from the North and is designed primarily for wealthy markets. Using nano-scale technologies, the pharmaceutical industry’s ultimate goal is to make every person a patient and every patient a paying customer by “medicating” social ills with human performance enhancement (HyPE) drugs and devices. Nanoenabled HyPEs could usher in an era of... Read more

19th May 2006 NEWS RELEASE

Global Coalition Sounds the Alarm on Synthetic Biology, Demands Oversight and Societal Debate

Today, a coalition of thirty-eight international organizations including scientists, environmentalists, trade unionists, biowarfare experts and social justice advocates called for inclusive public debate, regulation and oversight of the rapidly advancing field of synthetic biology - the construction of unique and novel artificial life forms to perform specific tasks. Synthetic biologists are meeting this weekend in Berkeley, California where they plan to announce a voluntary code of self-regulation for their work (1). The organizations signing the Open Letter are calling on synthetic biologists to abandon their proposals for self-governance and to engage in an inclusive process of global societal debate on the implications of their work (see attached Open Letter).

"The researchers meeting in Berkeley acknowledge the dangers of... Read more